The association between e-cigarette use and dyslipidemia: A systematic review and meta-analysis of observational studies
- 1College of Medicine, QU Health, Qatar University, Doha, Qatar.
- 2Department of Science and Mathematics, School of Interdisciplinary Arts and Sciences, University of Washington, Tacoma, Washington, United States of America.
Abstract
Background: E-cigarette use, also known as vaping, has rapidly increased in recent years, often marketed as a safer alternative to traditional smoking. While the cardiovascular risks of vaping are increasingly being recognized, its relationship with dyslipidemia remains unclear. This systematic review and meta-analysis evaluated the association between e-cigarette use and serum lipid levels, specifically total cholesterol (TC), high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), and triglycerides (TG). Methods: A search of PubMed, Scopus, EMBASE, CENTRAL, CINAHL, medRxiv, and Google Scholar was conducted up to May 31,2025. Eligible studies included adult populations and assessed the association between exclusive e-cigarette use and lipids. Study quality was assessed using the Methodological Standards for Epidemiological Research (MASTER) scale. Meta-analysis of adjusted odds ratios (aOR) for dyslipidemia and unadjusted weighted mean differences (uWMD) for each lipid was conducted using a bias-adjusted inverse-variance heterogeneity method. Heterogeneity was assessed using the I2 statistic, and publication bias using Doi plots and the LFK index, with the LFK index used as the primary quantitative criterion. Planned subgroup analyses by age group and sex could not be performed due to insufficient stratified reporting in included studies. The overall quality of evidence for each lipid outcome was evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework, Results: Of 4,160 identified data sources, seven observational studies from the U.S.A., South Korea, Romania, and Iraq with a total of 25,690 participants met the inclusion criteria. Meta-analysis showed that vaping was associated with higher odds of hypertriglyceridemia (aOR 3.10, 95% CI 1.18 to 8.16, I2 = 80.1%, LFK = 1.34), and higher odds of low HDL (aOR 3.26, 95% CI 2.28 to 4.65, I2 = 3.1%, LFK = 1.41). In studies with unadjusted mean lipid levels, the primary quality-effects model showed no statistically significant difference in TC (unadjusted weighted mean difference (uWMD) +3.66 mg/dL, 95% CI -13.89 to 21.20, I2 = 86.9%, LFK = 9.44) but showed higher LDL (uWMD +12.40 mg/dL, 95% CI 7.91 to 16.88, I2 = 29.1%, LFK = 1.05), and VLDL (uWMD +3.23 mg/dL, 95% CI 1.43 to 5.02, I2 = 0.0%, publication bias not assessed). For all outcomes, the GRADE certainty of evidence was very low. Conclusion: This synthesis suggests that e-cigarette use may be associated with adverse lipid profiles, but the evidence remains observational and of very low certainty, limiting causal inference. Further well-designed longitudinal studies, using validated smoking-status assessment, detailed vaping exposure measures, fasting lipid panels, repeated lipid measurements, and adjustment for key cardiometabolic confounders, are needed to clarify these associations.
Related
- Regarding the inference of causality in observational non-controlled studies. Comment on “Assessment of sexual function and its association with quality of life and disease severity in patients with atopic dermatitis”
- A simple sensitivity analysis for observational studies
- Win-Ratio Regression for Prioritized Composite Outcomes in Observational Studies: Doubly Robust and Efficient Estimation with Future-Score Correction
- Doubly Robust Estimation and Inference for Longitudinal Win Probabilities with Ordinal Outcomes in Observational Studies
- Practical guidance for collecting reproducible time-to-event endpoints in retrospective observational oncology studies.
BibTeX
@article{rajha2026association,
title = {{The association between e-cigarette use and dyslipidemia: A systematic review and meta-analysis of observational studies}},
author = {Humam Emad Rajha and Sara Mohsen and Hadeel Alkuwari and Janatul Naeim and Wejdan Al-Marri and Ahmad Hamdan and Tawanda Chivese and Rafif Mahmood Al Saady},
journal = {PLOS One},
year = {2026},
month = oct,
doi = {10.1371/journal.pone.0361200},
url = {https://doi.org/10.1371/journal.pone.0361200},
note = {CC BY},
}
RIS
TY - JOUR
TI - The association between e-cigarette use and dyslipidemia: A systematic review and meta-analysis of observational studies
AU - Humam Emad Rajha
AU - Sara Mohsen
AU - Hadeel Alkuwari
AU - Janatul Naeim
AU - Wejdan Al-Marri
AU - Ahmad Hamdan
AU - Tawanda Chivese
AU - Rafif Mahmood Al Saady
PY - 2026
DA - 2026/10/26
JO - PLOS One
DO - 10.1371/journal.pone.0361200
UR - https://doi.org/10.1371/journal.pone.0361200
AB - Background: E-cigarette use, also known as vaping, has rapidly increased in recent years, often marketed as a safer alternative to traditional smoking. While the cardiovascular risks of vaping are increasingly being recognized, its relationship with dyslipidemia remains unclear. This systematic review and meta-analysis evaluated the association between e-cigarette use and serum lipid levels, specifically total cholesterol (TC), high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), and triglycerides (TG). Methods: A search of PubMed, Scopus, EMBASE, CENTRAL, CINAHL, medRxiv, and Google Scholar was conducted up to May 31,2025. Eligible studies included adult populations and assessed the association between exclusive e-cigarette use and lipids. Study quality was assessed using the Methodological Standards for Epidemiological Research (MASTER) scale. Meta-analysis of adjusted odds ratios (aOR) for dyslipidemia and unadjusted weighted mean differences (uWMD) for each lipid was conducted using a bias-adjusted inverse-variance heterogeneity method. Heterogeneity was assessed using the I2 statistic, and publication bias using Doi plots and the LFK index, with the LFK index used as the primary quantitative criterion. Planned subgroup analyses by age group and sex could not be performed due to insufficient stratified reporting in included studies. The overall quality of evidence for each lipid outcome was evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework, Results: Of 4,160 identified data sources, seven observational studies from the U.S.A., South Korea, Romania, and Iraq with a total of 25,690 participants met the inclusion criteria. Meta-analysis showed that vaping was associated with higher odds of hypertriglyceridemia (aOR 3.10, 95% CI 1.18 to 8.16, I2 = 80.1%, LFK = 1.34), and higher odds of low HDL (aOR 3.26, 95% CI 2.28 to 4.65, I2 = 3.1%, LFK = 1.41). In studies with unadjusted mean lipid levels, the primary quality-effects model showed no statistically significant difference in TC (unadjusted weighted mean difference (uWMD) +3.66 mg/dL, 95% CI -13.89 to 21.20, I2 = 86.9%, LFK = 9.44) but showed higher LDL (uWMD +12.40 mg/dL, 95% CI 7.91 to 16.88, I2 = 29.1%, LFK = 1.05), and VLDL (uWMD +3.23 mg/dL, 95% CI 1.43 to 5.02, I2 = 0.0%, publication bias not assessed). For all outcomes, the GRADE certainty of evidence was very low. Conclusion: This synthesis suggests that e-cigarette use may be associated with adverse lipid profiles, but the evidence remains observational and of very low certainty, limiting causal inference. Further well-designed longitudinal studies, using validated smoking-status assessment, detailed vaping exposure measures, fasting lipid panels, repeated lipid measurements, and adjustment for key cardiometabolic confounders, are needed to clarify these associations.
SN - 1932-6203
ER -